β-Cyclodextrin-Grafted Polypyrrole-Rhodamine B Nanoplatforms for Drug Delivery and Image-Guided Photothermal Therapy In Vitro.

Shasha Hong, Yuan Jiao, Ruyu Li, Peng Lei, Chuan Dong, Shang Guo, Shaomin Shuang

Abstract read

In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shasha HongShanxi Institute for Functional Food, Shanxi Agricultural University, Taiyuan 030031, China.

Yuan JiaoCollege of Environment and Ecology, Taiyuan University of Technology, Jinzhong 030600, China.ORCID 0000-0001-5223-0885

Ruyu LiInstitute of Environmental Science, College of Chemistry and Chemical Engineering, Shanxi University, Taiyuan 030006, China.

Peng LeiInstitute of Environmental Science, College of Chemistry and Chemical Engineering, Shanxi University, Taiyuan 030006, China.

Chuan DongInstitute of Environmental Science, College of Chemistry and Chemical Engineering, Shanxi University, Taiyuan 030006, China.

Shang GuoShanxi Institute for Functional Food, Shanxi Agricultural University, Taiyuan 030031, China.

Shaomin ShuangInstitute of Environmental Science, College of Chemistry and Chemical Engineering, Shanxi University, Taiyuan 030006, China.

Funding

Shanxi Agricultural University Doctoral Research Initiation Project 2021BQ122Shanxi Province doctoral graduates and postdoctoral researchers come to work in Shanxi Province to reward the fund scientific research project SXBYKY2022076the earmarked fund for Modern Agro-industry Technology Research System 2025CYJSTX10the Natural Science Foundation of Shanxi Province 202203021212443

6 · The paper itself

Abstract

Synergetic therapeutic study using multifunctional nanoplatforms has been developed as an innovative modality for effective cancer treatment to improve the clinical efficiency of anticancer drugs and reduce severe off-target side effects. Herein, an artificial nanoplatform (denoted as PPy-RhB-PDA-CD-LA) was prepared by grafting β-cyclodextrin (β-CD) derivatives and lactobionic acid (LA) on the surface of rhodamine B (RhB)-doped polypyrrole nanoparticles (PPy-RhB NPs) using polydopamine (PDA) as the intermediate linker. Doxorubicin (DOX) was selected and successfully loaded onto the nanoplatforms with a high loading content of 327 mg/g. Furthermore, significant NIR light-triggered release of DOX was observed in a weak acidic tumor microenvironment. The nanoplatform exhibited superior photostability with a high photothermal effect of 51.7% under irradiation by a 808 nm laser and a competent temperature sensitivity (SR is 1.44% °C

Indexed as

drug deliverypolypyrrolerhodamine Bthermal sensingβ-cyclodextrins

Identifiers

PMID41374154

DOI10.3390/ma18235313

PMCPMC12693271

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.